How do the primary analysis results of the MIRASOL trial differ from the primary analysis results? Were there any unexpected findings? Back then, when we did the primary analysis, we had a follow ...
Full FDA approval was granted based on the phase 3 MIRASOL trial results, reinforcing its clinical benefits. Experts recommend mirvetuximab soravtansine as the standard of care, highlighting the ...
Elahere showed superior efficacy over chemotherapy in progression-free survival, objective response rate, and overall survival in the MIRASOL trial. The treatment reduced the risk of tumor progression ...
Hosted on MSN18d
AbbVie announces final analysis of Phase 3 MIRASOL trialAbbVie (ABBV) announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the efficacy and safety of ELAHERE in women with folate receptor alpha-positive platinum-resistant ...
Final data analysis from Phase 3 MIRASOL trial after 30.5-month median follow-up demonstrated 32% reduction in risk of death with ELAHERE compared to chemotherapy in folate receptor alpha (FRα ...
US-based pharmaceutical company AbbVie has reported the final analysis from the Phase III MIRASOL trial, which assessed its antibody-drug conjugate (ADC) Elahere against chemotherapy for treating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback